Copyright
©The Author(s) 2022.
World J Gastroenterol. May 7, 2022; 28(17): 1781-1797
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1781
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1781
Clinicopathological variables | Cohort tumor HB-EGF expression | P value | ||
Negative (n = 26) | Positive (n = 39) | |||
Age (yr) | 65.72 (10.37) | 69.43 (7.98) | ||
Gender | Female | 11 | 23 | > 0.05 |
Male | 14 | 16 | ||
Size of tumor (mm) | ≤ 10 | 5 | 7 | > 0.05 |
> 10 | 21 | 32 | ||
Lymphatic metastasis | Absent | 19 | 19 | > 0.05 |
Present | 7 | 20 | ||
Tumor differentiation | I-II | 12 | 24 | > 0.05 |
III-IV | 14 | 15 | ||
TNM stage | I-II | 11 | 8 | > 0.05 |
III-IV | 15 | 31 | ||
AJCC clinical stage according to 7th issue | 1 and 2A | 17 | 24 | > 0.05 |
3 and 3B | 9 | 15 |
- Citation: Zhang JJ, Cao CX, Wan LL, Zhang W, Liu ZJ, Wang JL, Guo Q, Tang H. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway. World J Gastroenterol 2022; 28(17): 1781-1797
- URL: https://www.wjgnet.com/1007-9327/full/v28/i17/1781.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i17.1781